Research abstract
British Dental Journal 194, 153 - 157 (2003)
Published online: 8 February 2003 | doi:10.1038/sj.bdj.4809898
An investigation into the comparative efficacy of soluble aspirin and solid paracetamol in postoperative pain after third molar surgery
R A Seymour1, J E Hawkesford2, J Sykes3, M Stillings4 & C M Hill5
- This study has shown the benefits of soluble aspirin (900 mg) over solid paracetamol (1,000 mg) in the control of postoperative pain after third molar extractions.
- The aspirin preparation provided an earlier onset of pain relief when compared with paracetamol.
- Most patients in the study did require additional analgesia in the early postoperative period, but the time to remedication was significantly longer in soluble aspirin group when compared with the placebo.
- Adverse events due to the medication were few and showed no differences between treatment groups.
- Soluble aspirin 900 mg appears to be a more useful analgesic than paracetamol in the control of postoperative pain after third molar surgery
Abstract
Objective To compare the efficacy of soluble aspirin 900 mg and paracetamol 1,000 mg in patients with postoperative pain after third molar surgery.
Design A randomised, placebo controlled, double-blind study.
Setting Day stay units of Oral and Maxillofacial Surgery at Cardiff Dental Hospital and Hexham General Hospital, Northumberland.
Subjects and methods One hundred and sixty-seven (104 female) patients who required the removal of their impacted third molars under general anaesthesia.
Intervention In the early postoperative period, patients were medicated with either a single dose of soluble aspirin 900 mg, solid paracetamol 1,000 mg or placebo.
Main outcome measures Pain intensity was measured on 100 mm visual analogue scales at 0, 5, 10, 15, 20, 30, 45, 60, 90, 120 and 240 minutes after dosing. Other efficacy variables evaluated included time to rescue medication and an overall assessment of the study medication efficacy by the patient on completion of the study.
Results One hundred and sixty-seven patients consented to take part in the study, but only 153 were medicated. Of the 14 patients not treated, 10 failed to develop sufficient pain to enter the study, two withdrew consent, one had an adverse reaction to the general anaesthetic and one was a protocol violator. Over the four hour investigation period, patients treated with soluble aspirin reported significantly less pain when compared with those treated with paracetamol (mean difference in AUC0-240 = -2001, 95% CI -3893 to -109, p=0.038) and placebo (mean difference in AUC0-240 = -3470, 95% CI -5719 to -1221, p=0.003). Similarly, at 20 and 30 minutes after dosing, patients in the soluble aspirin group were reporting significantly less pain than those in the paracetamol treatment group (mean difference in pain intensity: at 20 minutes -7.9, 95% CI -15.3 to -0.6, p=0.035; at 30 minutes -10.6, 95% CI -18.6 to -2.6, p=0.010). There were no significant differences between treatment groups with respect to the number of patients requiring rescue medication, however the time to dosing was significantly longer for those taking soluble aspirin when compared with placebo (hazard ratio 2.34, 95% CI 1.41 to 3.88, p<0.001).
Conclusion The findings from this study showed that soluble aspirin 900 mg provides significant and more rapid analgesia than paracetamol 1,000 mg in the early postoperative period after third molar surgery.
- Head of Department, Professor of Restorative Dentistry, Department of Restorative Dentistry, Dental School, University of Newcastle, Newcastle upon Tyne
- Consultant Oral and Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Newcastle General Hospital, Newcastle upon Tyne
- Clinical Statistician, Reckitt Benckiser Healthcare (UK), Hull
- Head of Global Professional Relations, Reckitt Benckiser Healthcare (UK), Hull
- Consultant Oral and Maxillofacial Surgeon, Department of Oral Surgery, Dental School, University of Wales College of Medicine, Cardiff
Correspondence to: R A Seymour1
Department of Restorative Dentistry, Dental School, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne, England NE2 4BW
e-mail: R. A. Seymour@ncl.ac.uk
